{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:33:22Z","timestamp":1762018402431,"version":"build-2065373602"},"reference-count":28,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2019]]},"DOI":"10.1620\/tjem.249.127","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T22:15:21Z","timestamp":1572473721000},"page":"127-133","source":"Crossref","is-referenced-by-count":5,"title":["Glomerular Injury Is Exacerbated in Lupus-Prone MRL\/lpr Mice Treated with a Protease-Activated Receptor 2 Antagonist"],"prefix":"10.1620","volume":"249","author":[{"given":"Rina","family":"Itto","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Oe","sequence":"additional","affiliation":[{"name":"Division of Feto-Maternal Medical Science, Department of Community Medical Support, Tohoku Medical Megabank Organization, Tohoku University"},{"name":"Research Fellow of Japan Society for the Promotion of Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Imaruoka","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences"},{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyo","family":"Sekimoto","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences"},{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Yamakage","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kumakura","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences"},{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences"},{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","unstructured":"Bode, M.F., Auriemma, A.C., Grover, S.P., Hisada, Y., Rennie, A., Bode, W.D., Vora, R., Subramaniam, S., Cooley, B., Andrade-Gordon, P., Antoniak, S. &amp; Mackman, N. (2018) The factor Xa inhibitor rivaroxaban reduces cardiac dysfunction in a mouse model of myocardial infarction. <i>Thromb. Res<\/i>., 167, 128-134."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Cheng, R.K.Y., Fiez-Vandal, C., Schlenker, O., Edman, K., Aggeler, B., Brown, D.G., Brown, G.A., Cooke, R.M., Dumelin, C.E., Dor\u00e9, A.S., Geschwindner, S., Grebner, C., Hermansson, N.O., Jazayeri, A., Johansson, P., et al. (2017) Structural insight into allosteric modulation of protease-activated receptor 2. <i>Nature<\/i>, 545, 112-115.","DOI":"10.1038\/nature22309"},{"key":"3","unstructured":"Cohen, P.L. &amp; Eisenberg, R.A. (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. <i>Annu. Rev. Immunol<\/i>., 9, 243-269."},{"key":"4","doi-asserted-by":"crossref","unstructured":"De Campo, B.A. &amp; Henry, P.J. (2005) Stimulation of protease-activated receptor-2 inhibits airway eosinophilia, hyperresponsiveness and bronchoconstriction in a murine model of allergic inflammation. <i>Br. J. Pharmacol<\/i>., 144, 1100-1108.","DOI":"10.1038\/sj.bjp.0706150"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Hansen, K.K., Sherman, P.M., Cellars, L., Andrade-Gordon, P., Pan, Z., Baruch, A., Wallace, J.L., Hollenberg, M.D. &amp; Vergnolle, N. (2005) A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. <i>Proc. Natl. Acad. Sci. USA<\/i>, 102, 8363-8368.","DOI":"10.1073\/pnas.0409535102"},{"key":"6","unstructured":"Hayashi, S., Oe, Y., Fushima, T., Sato, E., Sato, H., Ito, S. &amp; Takahashi, N. (2017) Protease-activated receptor 2 exacerbates adenine-induced renal tubulointerstitial injury in mice. <i>Biochem. Biophys. Res. Commun<\/i>., 483, 547-552."},{"key":"7","unstructured":"Imaruoka, K., Oe, Y., Fushima, T., Sato, E., Sekimoto, A., Sato, H., Sugawara, J., Ito, S. &amp; Takahashi, N. (2019) Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL\/lpr mice treated with lipopolysaccharide. <i>Biochem. Biophys. Res. Commun<\/i>., 510, 587-593."},{"key":"8","unstructured":"Kaneider, N.C., Leger, A.J., Agarwal, A., Nguyen, N., Perides, G., Derian, C., Covic, L. &amp; Kuliopulos, A. (2007) \u2018Role reversal\u2019 for the receptor PAR1 in sepsis-induced vascular damage. <i>Nat. Immunol<\/i>., 8, 1303-1312."},{"key":"9","unstructured":"Kumar Vr, S., Darisipudi, M.N., Steiger, S., Devarapu, S.K., Tato, M., Kukarni, O.P., Mulay, S.R., Thomasova, D., Popper, B., Demleitner, J., Zuchtriegel, G., Reichel, C., Cohen, C.D., Lindenmeyer, M.T., Liapis, H., et al. (2016) Cathepsin S cleavage of protease-activated receptor-2 on endothelial cells promotes microvascular diabetes complications. <i>J. Am. Soc. Nephrol<\/i>., 27, 1635-1649."},{"key":"10","doi-asserted-by":"crossref","unstructured":"Levi, M. &amp; van der Poll, T. (2010) Inflammation and coagulation. <i>Crit. Care Med<\/i>., 38, S26-34.","DOI":"10.1097\/CCM.0b013e3181c98d21"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Li, F., Wang, C.H., Wang, J.G., Thai, T., Boysen, G., Xu, L., Turner, A.L., Wolberg, A.S., Mackman, N., Maeda, N. &amp; Takahashi, N. (2010) Elevated tissue factor expression contributes to exacerbated diabetic nephropathy in mice lacking eNOS fed a high fat diet. <i>J. Thromb. Haemost<\/i>., 8, 2122-2132.","DOI":"10.1111\/j.1538-7836.2010.03976.x"},{"key":"12","unstructured":"Liang, Y., Leng, R.X., Pan, H.F. &amp; Ye, D.Q. (2016) Effects of disease activity and inflammatory response on hypercoagulability in patients with systemic lupus erythematosus. <i>Arch. Med. Res<\/i>., 47, 573-579."},{"key":"13","unstructured":"Lim, J., Iyer, A., Liu, L., Suen, J.Y., Lohman, R.J., Seow, V., Yau, M.K., Brown, L. &amp; Fairlie, D.P. (2013) Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism. <i>FASEB J<\/i>., 27, 4757-4767."},{"key":"14","unstructured":"Moussa, L., Apostolopoulos, J., Davenport, P., Tchongue, J. &amp; Tipping, P.G. (2007) Protease-activated receptor-2 augments experimental crescentic glomerulonephritis. <i>Am. J. Pathol<\/i>., 171, 800-808."},{"key":"15","unstructured":"Oe, Y., Fushima, T., Sato, E., Sekimoto, A., Kisu, K., Sato, H., Sugawara, J., Ito, S. &amp; Takahashi, N. (2019) Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury. <i>Sci. Rep<\/i>., 9, 2986."},{"key":"16","unstructured":"Oe, Y., Hayashi, S., Fushima, T., Sato, E., Kisu, K., Sato, H., Ito, S. &amp; Takahashi, N. (2016) Coagulation factor Xa and protease-activated receptor 2 as novel therapeutic targets for diabetic nephropathy. <i>Arterioscler. Thromb. Vasc. Biol<\/i>., 36, 1525-1533."},{"key":"17","unstructured":"Park, Y., Yang, J., Zhang, H., Chen, X. &amp; Zhang, C. (2011) Effect of PAR2 in regulating TNF-<i>\u03b1<\/i> and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice. <i>Basic Res. Cardiol<\/i>., 106, 111-123."},{"key":"18","doi-asserted-by":"crossref","unstructured":"Robertson, L., Kesteven, P. &amp; McCaslin, J.E. (2015) Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis. <i>Cochrane Database Syst. Rev.<\/i>, CD010956.","DOI":"10.1002\/14651858.CD010956.pub2"},{"key":"19","unstructured":"Rothmeier, A.S. &amp; Ruf, W. (2012) Protease-activated receptor 2 signaling in inflammation. <i>Semin. Immunopathol<\/i>., 34, 133-149."},{"key":"20","unstructured":"Sun, Y., Lu, Y., Engeland, C.G., Gordon, S.C. &amp; Sroussi, H.Y. (2013) The anti-oxidative, anti-inflammatory, and protective effect of S100A8 in endotoxemic mice. <i>Mol. Immunol<\/i>., 53, 443-449."},{"key":"21","unstructured":"Takahashi, N., Boysen, G., Li, F., Li, Y. &amp; Swenberg, J.A. (2007) Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate. <i>Kidney Int<\/i>., 71, 266-271."},{"key":"22","unstructured":"Tato, M., Kumar, S.V., Liu, Y., Mulay, S.R., Moll, S., Popper, B., Eberhard, J.N., Thomasova, D., Rufer, A.C., Gruner, S., Haap, W., Hartmann, G. &amp; Anders, H.J. (2017) Cathepsin S inhibition combines control of systemic and peripheral pathomechanisms of autoimmune tissue injury. <i>Sci. Rep<\/i>., 7, 2775."},{"key":"23","doi-asserted-by":"crossref","unstructured":"Tektonidou, M.G., Laskari, K., Panagiotakos, D.B. &amp; Moutsopoulos, H.M. (2009) Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. <i>Arthritis Rheum<\/i>., 61, 29-36.","DOI":"10.1002\/art.24232"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Vesey, D.A., Suen, J.Y., Seow, V., Lohman, R.J., Liu, L., Gobe, G.C., Johnson, D.W. &amp; Fairlie, D.P. (2013) PAR2-induced inflammatory responses in human kidney tubular epithelial cells. <i>Am. J. Physiol. Renal Physiol<\/i>., 304, F737-750.","DOI":"10.1152\/ajprenal.00540.2012"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Watanabe, M., Oe, Y., Sato, E., Sekimoto, A., Sato, H., Ito,S. &amp; Takahashi, N. (2019) Protease-activated receptor 2 exacerbates cisplatin-induced nephrotoxicity. <i>Am. J. Physiol. Renal Physiol<\/i>., 316, F654-F659.","DOI":"10.1152\/ajprenal.00489.2018"},{"key":"26","unstructured":"Witkowski, M., Landmesser, U. &amp; Rauch, U. (2016) Tissue factor as a link between inflammation and coagulation. <i>Trends Cardiovasc. Med<\/i>., 26, 297-303."},{"key":"27","unstructured":"Yamamoto, K., Loskutoff, D.J. &amp; Saito, H. (1998) Renal expression of fibrinolytic genes and tissue factor in a murine model of renal disease as a function of age. <i>Semin. Thromb. Hemost<\/i>., 24, 261-268."},{"key":"28","unstructured":"Yu, F., Haas, M., Glassock, R. &amp; Zhao, M.H. (2017) Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. <i>Nat. Rev. Nephrol.<\/i>, 13, 483-495."}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/249\/2\/249_127\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T08:50:20Z","timestamp":1695372620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/249\/2\/249_127\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.249.127","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"type":"print","value":"0040-8727"},{"type":"electronic","value":"1349-3329"}],"subject":[],"published":{"date-parts":[[2019]]}}}